Safety and tolerability of Vardenafil.
- Author:
Kai HONG
1
;
Hui JIANG
Author Information
1. Department of Urology, Third Affiliated People's Hospital, Peking University, Beijing 100083, China. kenhong99@sohu.com
- Publication Type:Journal Article
- MeSH:
Drug Tolerance;
Erectile Dysfunction;
drug therapy;
Humans;
Imidazoles;
adverse effects;
therapeutic use;
Male;
Middle Aged;
Phosphodiesterase Inhibitors;
adverse effects;
therapeutic use;
Piperazines;
adverse effects;
therapeutic use;
Sulfones;
adverse effects;
therapeutic use;
Treatment Outcome;
Triazines;
adverse effects;
therapeutic use;
Vardenafil Dihydrochloride
- From:National Journal of Andrology
2006;12(9):857-860
- CountryChina
- Language:Chinese
-
Abstract:
This paper reviewed the safety and tolerability of vardenafil in the treatment of erectile dysfunction (ED), including the general, cardiovascular and ocular safety. Results from clinical trials and practice experience demonstrated that vadenafil had good safety and tolerability, whether for general ED population or for difficult-to-treat ED patients, whether as short-term treatment or as long-term therapy.
